Cow's Milk Allergy Clinical Trial
— Petit LaitOfficial title:
Oral Immunotherapy in Cow's Milk Allergy (CMA) in Children : "Petit Lait" Study
Verified date | April 2017 |
Source | Association Poumon et Enfance |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Prospective study Main objective: to evaluate the efficiency and the security of two
protocols of immunotherapy (raw milk versus heated milk) in a cohort of children with
persistent Immunoglobulin E (IgE) mediated CMA (IgE-CMA).
Secondary objectives: to determinate if the enumeration of casein-specific IL-4- and
IL-13-secreting T cells could be a valuable biomarker of successful immunotherapy.
Status | Completed |
Enrollment | 50 |
Est. completion date | May 2016 |
Est. primary completion date | May 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Years to 18 Years |
Eligibility |
Inclusion Criteria: - All the children presenting with a diagnosis of IgE- CMA(defined as a history of reaction to the ingestion of cow's milk product and positive skin prick test (wheal =3 mm to cow's milk with no reaction to the negative control and specific IgE to casein >0.35 kU/l) Exclusion Criteria: - Children who have presented an anaphylactic reaction during the previously year, who reacted with placebo during the DBPCFC or those with lacking consent or parents having difficulties to understand the protocol |
Country | Name | City | State |
---|---|---|---|
France | Service d'Allergologie | Paris |
Lead Sponsor | Collaborator |
---|---|
Dr Flore AMAT |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical Outcome: increased tolerance to cow's milk | daily unit dose in milliliters of milk ingested | 12 months | |
Primary | Clinical Outcome: occurrence of allergic reaction to cow's milk | Number of patients with occurrence of allergic reaction; if yes, severity of allergic reaction evaluated using: Astier score; number of use of rescue medications such as: bronchodilator, anti-histaminics, systemic corticosteroids, epinephrin | 12 months | |
Secondary | Biological Outcome: kinetics of specific IgE against casein | changes in blood level of specific IgE against casein | 12 months | |
Secondary | Biological Outcome: kinetics of specific IgG4 against casein | changes in blood level of specific IgG4 against casein | 12 months | |
Secondary | Biological Outcome: kinetics of IL4 secreting lymphocytes against casein | ELISPOT assay | 12 months | |
Secondary | Biological Outcome: kinetics of IL13 secreting lymphocytes against casein | ELISPOT assay | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02738060 -
The Effect of Baked Milk on Cow's Milk Allergy
|
Phase 2 | |
Recruiting |
NCT02149134 -
Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy
|
Phase 2 | |
Recruiting |
NCT01891916 -
Effect Of Lactobacillus GG on Atopic March
|
N/A | |
Completed |
NCT01634490 -
Effects of Different Dietary Regimens on Tolerance Acquisition in Children With Cow's Milk Allergy
|
N/A | |
Completed |
NCT01622426 -
Tolerance to a New Free Amino Acid-based Formula in Children With IgE or Non-IgE-mediated Cow's Milk Allergy
|
N/A | |
Completed |
NCT02466035 -
Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA)
|
N/A | |
Completed |
NCT02379598 -
Effect of Therapy With Aminoacid Based Formula Versus Hydrolyzed Whey Proteins in Children With Cow's Milk Allergy
|
N/A | |
Completed |
NCT04330092 -
Diagnosis of Cow's Milk Protein Allergy
|
||
Not yet recruiting |
NCT02081651 -
Parmigiano-Reggiano Cheese as a Possible Strategy to Acquire Oral Tolerance in Children With Cow's Milk Allergy
|
Phase 3 | |
Completed |
NCT03462030 -
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
|
Phase 2 | |
Suspended |
NCT05731206 -
Hypoallergenicity of a Hydrolyzed Protein Infant Formula
|
N/A | |
Not yet recruiting |
NCT06456541 -
Infant Formula in Infants and Children With Cow's Milk Allergy
|
N/A | |
Recruiting |
NCT02062476 -
Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy
|
Phase 2 | |
Completed |
NCT01589731 -
Polymerized Beta-lactoglobulin Comparative Immunoreactivity
|
N/A | |
Terminated |
NCT02405923 -
Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy
|
N/A | |
Terminated |
NCT04910373 -
Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy
|
N/A | |
Recruiting |
NCT01968278 -
Use of Baked Milk in Oral Immunotherapy for Severe IgE-mediated Cow's Milk Protein Allergic Patients
|
N/A | |
Withdrawn |
NCT01470768 -
Evaluation of Fatty Acid Levels and Growth in Infants Fed Amino Acid Based (AA) Formulas
|
N/A | |
Recruiting |
NCT05883384 -
Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein Alergy
|
||
Completed |
NCT01901380 -
Cow's Milk Allergy and Functional Gastrointestinal Disorders
|
N/A |